Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Understanding zero based budgeting in detail equips you with vital financial management skills. Dive deep into this effective budgeting method.
16,114 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Navitas Semiconductor is pursuing an AI data-center power strategy built around 800V architecture. This move could re...
GE Vernova sparked intraday excitement as investors reacted to new outlooks on its energy portfolio. This piece break...
Oxford Square Capital trades at a 24% yield, yet a steep NAV decline and Q4 losses cast doubt on earnings durability....
MaxCyte's 2025 earnings journey hinges on platform momentum, partnerships, and cash discipline. This guide breaks dow...
As AI reshapes business, three stock ideas stand out for potential multi-year gains. This guide breaks down why, how ...
Spotlighting two strong growth names that could exceed Summit Therapeutics in a year. Learn the catalysts, risks, and...
The Nasdaq down from high has created a disciplined buying moment for patient investors. This guide highlights five t...
Gemini Space Station stock has faced a sharp weekly drop as analysts trim targets after a mixed earnings update. This...
The latest CBO outlook warns the OASI trust fund could run dry by 2032 if reforms stall, signaling potential changes ...
Want to furnish on a budget without sacrificing style? This guide shares 10 practical tips to find tips best deals us...
Yara International’s chief executive outlines a relentless, all-out strategy to weather Middle East tensions, signali...